Molecular and Chemical Neuropathology

, Volume 11, Issue 1, pp 33–43 | Cite as

Prevention of delayed neuronal death in gerbil hippocampus by a novel vinca alkaloid derivative (Vinconate)

  • Tsutomu Araki
  • Kyuya Kogure
Original Articles


We investigated the effect of vinconate, a novel vinca alkaloid derivative, on delayed neuronal death using Mongolian gerbils. The animals were allowed to survive for 7 d after 3 or 5 min of forebrain ischemia induced by bilateral occlusion of the common carotid arteries. Morphological changes and calcium (45Ca) accumulation were evaluated in the CA1 sector of the hippocampus after ischemia. Vinconate (50, 100, and 300 mg/kg) showed protective effects against neuronal death in a dose-dependent manner when administered intraperitoneally (ip) 10 min before 5 min of ischemia. However, the administration of vinconate (100 and 300 mg/kg, ip) immediately after 5 min of ischemia showed no therapeutic effect, whereas a marked therapeutic effect of vinconate (50 and 100 mg/kg, ip) was observed when administered immediately after 3 min of ischemia. An anesthetic dose of pentobarbital (40 mg/kg, ip) also produced significant protection against neuronal death. Furthermore, a45Ca autoradiographic study indicated that a marked calcium accumulation was found in the CA1 sector at 7 d after 5 min of ischemia, which was consistent with the extent of histological neuronal damage. When vinconate (100 and 300 mg/kg, ip) was administered 10 min before 5 min of ischemia, the abnormal calcium accumulation was not detected in the CA1 sector. These data indicate that suppression of abnormal neuronal activity may be owing to the antagonistic action of vinconate on calcium accumulation.

Index Entries

Selective vulnerability 45Ca hippocampus delayed neuronal death gerbil Vinconate 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Alps B. J., Calder C., Hass W. K., and Wilson A. D. (1988) Comparative protective effects of nicardipine, flunarizine, lidoflazine and nimodipine against ischaemic injury in the hippocampus of the Mongolian gerbils.Br. J. Pharmacol. 93, 877–883.PubMedGoogle Scholar
  2. Benveniste H., Drejer J., Schousboe A., and Diemer N. H. (1984) Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis.J. Neurochem. 43, 1369–1374.PubMedCrossRefGoogle Scholar
  3. Caravaggi A. M., Sardi A., Baldoli E., Di Francesco G. F., and Luca C. (1977) Hemodynamic profile of a new cerebral vasodilator, vincamine and of one of its derivatives, apovincaminic acid ethylester (RGH-4405)(1).Arch. Int. Pharmacodyn. 226, 139–148.PubMedGoogle Scholar
  4. Cotman C. W., Monaghan D. T., Ottersen O. P., and Storm-Mathisen J (1987) Anatomical organization of excitatory amino acid receptors and their pathways.Trend. Neurosci. 10, 273–280.CrossRefGoogle Scholar
  5. Deshpande J. K. and Wieloch T. (1985) Amelioration of ischaemic brain damage by postischaemic treatment with flunarizine.Neurol. Res. 7, 27–29.PubMedGoogle Scholar
  6. Deshpande J. K., Siesjö B. K., and Wieloch T. (1987) Calcium accumulation and neuronal damage in the rat hippocampus following cerebral ischemia.J. Cereb. Blood Flow Metab. 7, 89–95.PubMedGoogle Scholar
  7. Dienel G. A. (1984) Regional accumulation of calcium in postischemic rat brain.J. Neurochem. 43, 913–925.PubMedCrossRefGoogle Scholar
  8. Gill R., Foster A. C., and Woodruff G. N. (1988) MK-801 is neuroprotective in gerbils when administered during the post-ischaemic period.Neuroscience 25, 847–855.PubMedCrossRefGoogle Scholar
  9. Izumiyama K. and Kogure K. (1988) Prevention of delayed neuronal death in gerbil hippocampus by ion channel blockers.Stroke 19, 1003–1007.PubMedGoogle Scholar
  10. Johansen F. F., Jorgensen M. B., and Diemer N. H. (1986) Ischemic CA-1 pyramidal cell loss is prevented by preischemic colchicine destruction of dentate gyrus granule cells.Brain Res. 377, 344–347.PubMedCrossRefGoogle Scholar
  11. Jorgensen M. B., Johansen, F. F., and Diemer N. H. (1987) Removal of the entorhinal cortex protects hippocampal CA-1 neurons from ischemic damage.Acta Neuropathol. (Berlin)73, 189–194.CrossRefGoogle Scholar
  12. Kárpáti E. and Szporny L. (1976) General and cerebral haemodynamic activity of ethyl apovicaminate.Arzneim-Forsch 26, 1908–1912.Google Scholar
  13. Katsuragi T., Ohba M., Mori R., Kushiku K., and Furukawa T. (1984) Calcium antagonistic action involved in vasodilation by brovincamine.Gen. Pharmac. 15, 43–45.Google Scholar
  14. King G. A. (1987) Protective effects of vinpocetine and structurally related drugs on the lethal consequences of hypoxia in mice.Arch. Int. Pharmacodyn. 286, 299–307.PubMedGoogle Scholar
  15. Kirino T. (1982) Delayed neuronal death in the gerbil hippocampus following ischemia.Brain Res. 239, 57–69.PubMedCrossRefGoogle Scholar
  16. Kirino T. and Sano K. (1984a) Sefective vulnerability in the gerbil hippocampus following transient ischemia.Acta Neuropathol. (Berlin)62, 201–208.CrossRefGoogle Scholar
  17. Kirino T., Tamura A., and Sano K. (1986) A reversible type of neuronal injury following ischemia in the gerbil hippocampus.Stroke 17, 455–459.PubMedGoogle Scholar
  18. Mayo B. C., Biggs S. R., Hawkins D. R., Chasseaud L. F., Darragh A., Baldock G. A., and Whitby B. R. (1982) The metabolic fate of 11-bromo-[15-3H] vincamine in rats, dogs and humans.J. Pharm. Dyn. 5, 951–964.Google Scholar
  19. Mizon J. P., Gentit T., and Billecocq G. (1971) Les anemies refractaires sideroblastiques.Lille Med. 16, 1427–1429.PubMedGoogle Scholar
  20. Nedergaard M. (1988) Mechanisms of brain damage in focal cerebral ischemia.Acta Neurol. Scand. 77, 81–101.PubMedCrossRefGoogle Scholar
  21. Onodera H., Sato G., and Kogure K. (1986) Lesions to Schaffer collaterals prevent ischemic death of CA1 pyramidal cells.Neurosci. Lett. 68, 169–174.PubMedCrossRefGoogle Scholar
  22. Olpe H. R., Barrionuevo G., and Lynch G. (1982) Vincamine: A psychogeriatric agent blocking synaptic potentiation in hippocampus.Life Science 31, 1947–1953.CrossRefGoogle Scholar
  23. Pulsinelli W. A., Brierley J. B., and Plum F. (1982) Temporal profile of neuronal damage in a model of transient forebrain ischemia.Ann. Neurol. 11, 491–498.PubMedCrossRefGoogle Scholar
  24. Rothman S. M. and Olney J. W. (1986) Glutamate and the pathophysiology of hypoxic-ischemic brain damage.Ann. Neurol. 19, 105–111.PubMedCrossRefGoogle Scholar
  25. Rudolphi K. A., Keil M., and Hinze H. J. (1987) Effect of theophylline on ischemically induced hippocampal damage in mongolian gerbils. A behavioral and histopathological study.J. Cereb. Blood Flow Metab. 7, 74–81.PubMedGoogle Scholar
  26. Saletu B., Grunberger J., Linzmayer L., and Wittek, R. (1984) Classification and determination of pharmacodynamics of a new antihypoxidotic drug, vinconate, by pharmaco-EEG and psychometry.Arch. Gerontol. Geriatr. 3, 127–146.PubMedCrossRefGoogle Scholar
  27. Sakamoto N., Kogure K., Kato H., and Ohtomo H. (1985) Disturbed Ca2+ homeostasis in the gerbil hippocampus following brief transient ischemia.Brain Res. 364, 372–376.CrossRefGoogle Scholar
  28. Siesjö B. K. (1981) Cell damage in the brain: a speculative synthesis.J. Cereb. Blood Flow Metab. 1, 155–185.PubMedGoogle Scholar
  29. Simon R. P., Swan J. H., Griffiths T., and Meldrum B. S. (1984) Blockade ofN-methyl-D-aspartate receptor may protect against ischemic damage in the brain.Science 226, 850–852.PubMedCrossRefGoogle Scholar
  30. Suzuki R., Yamaguchi T., Li C.-L., and Klatzo, I. (1983) The effects of 5-min ischemia in mongolian gerbils. Changes of spontaneous neuronal activity in cerebral cortex and CA1 sector of hippocampus.Acta Neuropathol. (Berlin)60, 217–222.CrossRefGoogle Scholar
  31. Szobor A. and Klein M. (1976) Ethyl apovincaminate therapy in neurovascular diseases.Arzneim-Forsch 26, 1984–1989.Google Scholar
  32. Thiebauld C., Van Mullem J., Lintermans J., and Sprumont P. (1983) Testing in a hypobaric chamber drugs claimed to improve impaired brain functions.Lancet 2, 225, 226.Google Scholar
  33. Vereczkey L., Zolyomi G., and Szporny L. (1976) Pharmacokinetic data on tritium labelled ethyl apovincaminate.Arzneim-Forsch 26, 1929–1933.Google Scholar
  34. Wieloch T., Lindvall O., Blomqvist P., and Gage F. (1985) Evidence for amelioration of ischemic damage in the hippocampal formation by lesions of the perforant path.Neurol. Res. 7, 24–26.PubMedGoogle Scholar
  35. Zola-Morgan S., Squire L. R., and Amaral G. (1986) Human amnesia and the medial temporal region: enduring memory impairment following a bilateral lesion limited to field CA1 sector of the hippocampus.J. Neurosci. 6, 2950–2967.PubMedGoogle Scholar

Copyright information

© Humana Press Inc. 1989

Authors and Affiliations

  • Tsutomu Araki
    • 1
  • Kyuya Kogure
    • 1
  1. 1.Department of Neurology, Institute of Brain DiseasesTohoku University School of MedicineSendai, MiyagiJapan

Personalised recommendations